Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: J Immunol. 2013 May 29;191(1):415–423. doi: 10.4049/jimmunol.1201732

Figure 8.

Figure 8

Involvement of non-CD4 lymphoid cells in the inflammatory process in eyes of recipients treated with the TLR ligands. (A) Infiltrating cells were collected from recipient eyes on day 7 post-naïve CD4 cell injection and were examined by flow cytometry, with gating on CD45+ cell population, for expression of surface markers specific for CD8, macrophages and granulocytes. (B) Calculated percent values of cells expressing the markers among the CD45+ cell population.